Advocacy for Migraine Relief: Strategic Planning to Eliminate the Burden.

Authors:
Monteith TS.

Journal:
Curr Pain Headache Rep

Publication Year: 2022

DOI:
10.1007/s11916-022-01059-1

PMCID:
PMC9206221

PMID:
35716274

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Curr Pain Headache Rep

Abbreviation: Curr Pain Headache Rep

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Psychophysiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Acupuncture for Low Back Pain: Reevaluation of Systematic Reviews and Meta-analyses.
Yan WX; Lin HZ; Wang X and 4 more (2023) - Transparency Score: 3/6
Complex Regional Pain Syndrome (CRPS) and the Value of Early Detection.
Harnik MA; Kesselring P; Ott A and 2 more (2023) - Transparency Score: 3/6
Does Tension Headache Have a Central or Peripheral Origin? Current State of Affairs.
Repiso-Guardeño Á; Moreno-Morales N; Labajos-Manzanares MT and 2 more (2023) - Transparency Score: 3/6
Medical Cannabis for Chronic Nonmalignant Pain Management.
Hameed M; Prasad S; Jain E and 9 more (2023) - Transparency Score: 2/6
The Gut-brain Connection and Episodic Migraine: an Update.
Nguyen L; Hindiyeh N; Ray S and 2 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest Teshamae Monteith has received personal compensation for serving on advisory boards for Biohaven, Allegan/Abbvie, Lundbeck, Amgen, Teva, and Impel Neuropharmaceuticals. She has also served as a site principal investigator without direct compensation for Teva, Eli Lilly, Electrocore, Amgen, and Novartis."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025